Journey Medical Corporation Announces Upcoming Investor Conferences
Journey Medical Corporation's Participation in Key Investor Conferences
Journey Medical Corporation, known for its commitment to dermatological healthcare, has announced its participation in notable investor conferences this September. The company, which is publicly traded on Nasdaq under the ticker **DERM**, is dedicated to marketing FDA-approved prescription products aimed at treating common skin conditions.
Details of the Upcoming Conferences
CEO Claude Maraoui will represent Journey Medical at two significant events, spotlighting the company’s industry expertise and innovative approach. Here are the details:
H.C. Wainwright 27th Annual Global Investment Conference
This event is set for September 8, where Claude will engage in a fireside chat format along with personalized one-on-one meetings. This platform allows Journey Medical to share its vision and growth potential with investors and industry partners.
Lake Street Capital Markets 9th Annual Best Ideas Growth Conference
On September 11, Claude will also attend the Lake Street Capital Markets conference, continuing the dialogue with investors through focused one-on-one meetings. Both conferences are great opportunities for the company to connect with stakeholders and discuss strategic developments.
About Journey Medical Corporation
Founded by Fortress Biotech, Inc. and headquartered in Scottsdale, Arizona, Journey Medical Corporation is a commercial-stage pharmaceutical company dedicated to addressing dermatological conditions through a streamlined marketing model. The company currently markets eight branded prescription drugs, catering to a variety of skin ailments. With a team of seasoned experts in dermatology, Journey Medical prides itself on developing and commercializing successful prescription products that boost patient wellbeing.
Future Aspirations and Developments
Looking ahead, Journey Medical is not just focused on maintaining its current operations but aims to expand its portfolio of dermatological products. As the team collaborates on research and development, the company aspires to innovate and introduce even more solutions tailored to needs in dermatology.
Market Trends in Dermatology
The dermatological pharmaceutical market is expected to grow significantly as awareness of skin health continues to rise. Journey Medical’s strategic engagements during these investor conferences may set the stage for new products and partnerships, further solidifying its presence in the market.
Investor Engagement
Active participation in these conferences reinforces the company’s commitment to transparency and engagement with investors, offering them insights into its strategies and future directions. This initiative aligns with Journey Medical’s reputation as a forward-thinking player in the pharmaceutical landscape.
Company Contacts
For further inquiries, representatives from Journey Medical Corporation are available:
Contact for Investor Relations:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
(908) 591-2839
tplohoros@6degreespr.com
Frequently Asked Questions
What is Journey Medical Corporation's focus?
Journey Medical Corporation focuses primarily on selling and marketing FDA-approved prescription products for dermatological treatments.
Who will represent Journey Medical at the investor conferences?
Claude Maraoui, the Co-Founder, President, and CEO, will represent the company at both conferences.
Where will the upcoming investor conferences take place?
Both conferences are located in New York City, offering substantial networking opportunities.
What products does Journey Medical currently market?
The company markets eight branded prescription drugs targeted at treating various skin conditions.
How can investors learn more about Journey Medical?
Investors can gain insights by attending the conferences and are encouraged to reach out via provided contact channels for specific inquiries.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.